

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.65106943 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.65106943 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 5.65106943 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 5.65106943 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 5.65106943 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.65106943 |
| 7 | response to peptidoglycan (GO:0032494) | 5.43856823 |
| 8 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 5.33324746 |
| 9 | negative regulation of interleukin-12 production (GO:0032695) | 5.32049295 |
| 10 | negative regulation of cell killing (GO:0031342) | 5.26749312 |
| 11 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.26749312 |
| 12 | detection of molecule of bacterial origin (GO:0032490) | 5.26366529 |
| 13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.13474562 |
| 14 | macrophage activation involved in immune response (GO:0002281) | 4.93845444 |
| 15 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.92792125 |
| 16 | neutrophil activation involved in immune response (GO:0002283) | 4.72317118 |
| 17 | detection of other organism (GO:0098543) | 4.67476535 |
| 18 | cellular extravasation (GO:0045123) | 4.52815197 |
| 19 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.38207648 |
| 20 | detection of external biotic stimulus (GO:0098581) | 4.38091456 |
| 21 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.25971195 |
| 22 | neutrophil activation (GO:0042119) | 4.25384970 |
| 23 | leukocyte aggregation (GO:0070486) | 4.23034728 |
| 24 | detection of bacterium (GO:0016045) | 4.16462792 |
| 25 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.14675682 |
| 26 | granulocyte activation (GO:0036230) | 4.06088879 |
| 27 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.01508048 |
| 28 | immunoglobulin mediated immune response (GO:0016064) | 4.00721982 |
| 29 | detection of biotic stimulus (GO:0009595) | 3.98084735 |
| 30 | neutrophil mediated immunity (GO:0002446) | 3.95344729 |
| 31 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.93789304 |
| 32 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.92864365 |
| 33 | microglial cell activation (GO:0001774) | 3.89433781 |
| 34 | respiratory burst (GO:0045730) | 3.85735989 |
| 35 | macrophage activation (GO:0042116) | 3.84550866 |
| 36 | type I interferon signaling pathway (GO:0060337) | 3.83636617 |
| 37 | cellular response to type I interferon (GO:0071357) | 3.83636617 |
| 38 | response to host immune response (GO:0052572) | 3.82546473 |
| 39 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.82546473 |
| 40 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.79484010 |
| 41 | response to type I interferon (GO:0034340) | 3.77751386 |
| 42 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.76971610 |
| 43 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.76940355 |
| 44 | regulation of gamma-delta T cell activation (GO:0046643) | 3.71095681 |
| 45 | response to interleukin-15 (GO:0070672) | 3.68727198 |
| 46 | germinal center formation (GO:0002467) | 3.63571064 |
| 47 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.59997175 |
| 48 | T-helper 1 type immune response (GO:0042088) | 3.53574374 |
| 49 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.49894131 |
| 50 | defense response to protozoan (GO:0042832) | 3.49691806 |
| 51 | myeloid cell activation involved in immune response (GO:0002275) | 3.47285727 |
| 52 | cellular response to interleukin-15 (GO:0071350) | 3.43945519 |
| 53 | response to host (GO:0075136) | 3.43898076 |
| 54 | response to host defenses (GO:0052200) | 3.43898076 |
| 55 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.43898076 |
| 56 | negative regulation of T cell mediated immunity (GO:0002710) | 3.37862077 |
| 57 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.37448854 |
| 58 | regulation of interferon-alpha production (GO:0032647) | 3.37320197 |
| 59 | positive regulation of interferon-alpha production (GO:0032727) | 3.36651866 |
| 60 | regulation of T cell tolerance induction (GO:0002664) | 3.35720451 |
| 61 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.35296488 |
| 62 | B cell mediated immunity (GO:0019724) | 3.32068839 |
| 63 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.31715749 |
| 64 | myeloid leukocyte mediated immunity (GO:0002444) | 3.30535720 |
| 65 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.29695371 |
| 66 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.29583812 |
| 67 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.27592793 |
| 68 | regulation of tolerance induction (GO:0002643) | 3.27005506 |
| 69 | neutrophil chemotaxis (GO:0030593) | 3.23250074 |
| 70 | response to protozoan (GO:0001562) | 3.21292724 |
| 71 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.20191111 |
| 72 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.19126563 |
| 73 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.19003160 |
| 74 | positive regulation of type 2 immune response (GO:0002830) | 3.17232972 |
| 75 | neutrophil migration (GO:1990266) | 3.14881208 |
| 76 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.12346025 |
| 77 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.10984144 |
| 78 | response to muramyl dipeptide (GO:0032495) | 3.10280062 |
| 79 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.10161347 |
| 80 | regulation of mast cell degranulation (GO:0043304) | 3.08240093 |
| 81 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.07286650 |
| 82 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.07267754 |
| 83 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.07267754 |
| 84 | regulation of mast cell activation (GO:0033003) | 3.04875427 |
| 85 | positive regulation of mast cell activation (GO:0033005) | 3.03657486 |
| 86 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.03138525 |
| 87 | response to interferon-alpha (GO:0035455) | 3.01648039 |
| 88 | positive regulation of acute inflammatory response (GO:0002675) | 3.00354411 |
| 89 | myeloid leukocyte activation (GO:0002274) | 2.99590689 |
| 90 | positive regulation of interleukin-10 production (GO:0032733) | 2.97974351 |
| 91 | regulation of interleukin-12 production (GO:0032655) | 2.97951740 |
| 92 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.96834786 |
| 93 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.95615981 |
| 94 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.93637083 |
| 95 | positive regulation of interferon-beta production (GO:0032728) | 2.93007792 |
| 96 | regulation of regulatory T cell differentiation (GO:0045589) | 2.91415197 |
| 97 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.88626859 |
| 98 | cytokine secretion (GO:0050663) | 2.87353778 |
| 99 | positive regulation of tolerance induction (GO:0002645) | 2.87096115 |
| 100 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.84813920 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.69322100 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.91530359 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.98649772 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.62805285 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.00527145 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.71289750 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.64807711 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.54865009 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.50110369 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.32796345 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.25242621 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.20242499 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.12015642 |
| 14 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.03856652 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.80769354 |
| 16 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.78158641 |
| 17 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.61124368 |
| 18 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.59152155 |
| 19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.58243215 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.57578877 |
| 21 | MYB_26560356_Chip-Seq_TH2_Human | 2.30882960 |
| 22 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.24399953 |
| 23 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.21161938 |
| 24 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.12848146 |
| 25 | SPI1_23127762_ChIP-Seq_K562_Human | 2.12044506 |
| 26 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.10860617 |
| 27 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04866083 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.01315152 |
| 29 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.00233253 |
| 30 | MAF_26560356_Chip-Seq_TH1_Human | 1.92418258 |
| 31 | MYB_26560356_Chip-Seq_TH1_Human | 1.88706598 |
| 32 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.86309492 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.85987517 |
| 34 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.74719318 |
| 35 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.74211483 |
| 36 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.66093144 |
| 37 | GATA3_26560356_Chip-Seq_TH2_Human | 1.65610119 |
| 38 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.60142650 |
| 39 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.58901985 |
| 40 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.58728114 |
| 41 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.58076510 |
| 42 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.57392321 |
| 43 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.54328645 |
| 44 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51467017 |
| 45 | UTX_26944678_Chip-Seq_JUKART_Human | 1.51137199 |
| 46 | GATA1_22025678_ChIP-Seq_K562_Human | 1.51121549 |
| 47 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.50876410 |
| 48 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.50392332 |
| 49 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.49603802 |
| 50 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.48414678 |
| 51 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48380079 |
| 52 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.42034837 |
| 53 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35519673 |
| 54 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30804510 |
| 55 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.27446127 |
| 56 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.27172606 |
| 57 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.26865027 |
| 58 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25999663 |
| 59 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25521222 |
| 60 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24428754 |
| 61 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.22136704 |
| 62 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19900699 |
| 63 | MAF_26560356_Chip-Seq_TH2_Human | 1.17831986 |
| 64 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17784060 |
| 65 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10419032 |
| 66 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.10404787 |
| 67 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.10112609 |
| 68 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09719758 |
| 69 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.09679867 |
| 70 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.05529643 |
| 71 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03774714 |
| 72 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00836171 |
| 73 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.97970510 |
| 74 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.93775578 |
| 75 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.93540867 |
| 76 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.91809862 |
| 77 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.86271994 |
| 78 | MYC_22102868_ChIP-Seq_BL_Human | 0.85497088 |
| 79 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84374539 |
| 80 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.84318881 |
| 81 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82146887 |
| 82 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80843663 |
| 83 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.80216117 |
| 84 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.78239576 |
| 85 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.77104798 |
| 86 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.74920309 |
| 87 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.74263599 |
| 88 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.72409049 |
| 89 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.70306072 |
| 90 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.70297886 |
| 91 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.70006200 |
| 92 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.69636646 |
| 93 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.69478747 |
| 94 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.67669897 |
| 95 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.67225217 |
| 96 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.65157847 |
| 97 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.63691584 |
| 98 | GATA3_26560356_Chip-Seq_TH1_Human | 0.62781066 |
| 99 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.61519884 |
| 100 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.60394170 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 5.57306384 |
| 2 | MP0003303_peritoneal_inflammation | 4.66981778 |
| 3 | MP0003436_decreased_susceptibility_to | 4.20474858 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.70921333 |
| 5 | MP0009785_altered_susceptibility_to | 3.53916863 |
| 6 | MP0002419_abnormal_innate_immunity | 3.06198958 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 3.00512820 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.95651787 |
| 9 | MP0005671_abnormal_response_to | 2.89104891 |
| 10 | MP0005025_abnormal_response_to | 2.84023265 |
| 11 | MP0006082_CNS_inflammation | 2.81804697 |
| 12 | MP0001790_abnormal_immune_system | 2.81195836 |
| 13 | MP0005387_immune_system_phenotype | 2.81195836 |
| 14 | MP0001800_abnormal_humoral_immune | 2.74820092 |
| 15 | MP0000685_abnormal_immune_system | 2.62238202 |
| 16 | MP0002723_abnormal_immune_serum | 2.58924214 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.50205895 |
| 18 | MP0009764_decreased_sensitivity_to | 2.42606086 |
| 19 | MP0003300_gastrointestinal_ulcer | 2.35773807 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.31735366 |
| 21 | MP0001819_abnormal_immune_cell | 2.30297015 |
| 22 | MP0001533_abnormal_skeleton_physiology | 2.30009397 |
| 23 | MP0002405_respiratory_system_inflammati | 2.00703100 |
| 24 | MP0001845_abnormal_inflammatory_respons | 1.92233223 |
| 25 | MP0010155_abnormal_intestine_physiology | 1.90524916 |
| 26 | MP0004510_myositis | 1.88398665 |
| 27 | MP0004947_skin_inflammation | 1.82471398 |
| 28 | MP0003075_altered_response_to | 1.82063628 |
| 29 | MP0009278_abnormal_bone_marrow | 1.77359262 |
| 30 | MP0002277_abnormal_respiratory_mucosa | 1.74787046 |
| 31 | MP0003191_abnormal_cellular_cholesterol | 1.71679416 |
| 32 | MP0005451_abnormal_body_composition | 1.66905533 |
| 33 | MP0008004_abnormal_stomach_pH | 1.66278035 |
| 34 | MP0000716_abnormal_immune_system | 1.65694992 |
| 35 | MP0008469_abnormal_protein_level | 1.64871483 |
| 36 | MP0003828_pulmonary_edema | 1.58320108 |
| 37 | MP0002398_abnormal_bone_marrow | 1.58070300 |
| 38 | MP0005464_abnormal_platelet_physiology | 1.57764545 |
| 39 | MP0001853_heart_inflammation | 1.55627829 |
| 40 | MP0009333_abnormal_splenocyte_physiolog | 1.55419763 |
| 41 | MP0008260_abnormal_autophagy | 1.50171916 |
| 42 | MP0002132_abnormal_respiratory_system | 1.45861704 |
| 43 | MP0000343_altered_response_to | 1.44198140 |
| 44 | MP0003763_abnormal_thymus_physiology | 1.40190509 |
| 45 | MP0000465_gastrointestinal_hemorrhage | 1.38452569 |
| 46 | MP0005166_decreased_susceptibility_to | 1.38036718 |
| 47 | MP0005164_abnormal_response_to | 1.35855221 |
| 48 | MP0003806_abnormal_nucleotide_metabolis | 1.35719462 |
| 49 | MP0000689_abnormal_spleen_morphology | 1.32927184 |
| 50 | MP0003448_altered_tumor_morphology | 1.32157679 |
| 51 | MP0002722_abnormal_immune_system | 1.31621576 |
| 52 | MP0000858_altered_metastatic_potential | 1.29883762 |
| 53 | MP0002429_abnormal_blood_cell | 1.29045768 |
| 54 | MP0002332_abnormal_exercise_endurance | 1.26621861 |
| 55 | MP0001545_abnormal_hematopoietic_system | 1.26139480 |
| 56 | MP0005397_hematopoietic_system_phenotyp | 1.26139480 |
| 57 | MP0002998_abnormal_bone_remodeling | 1.24264528 |
| 58 | MP0005310_abnormal_salivary_gland | 1.19723915 |
| 59 | MP0005167_abnormal_blood-brain_barrier | 1.17840760 |
| 60 | MP0003866_abnormal_defecation | 1.13884263 |
| 61 | MP0004883_abnormal_blood_vessel | 1.08427498 |
| 62 | MP0009763_increased_sensitivity_to | 1.04282363 |
| 63 | MP0003172_abnormal_lysosome_physiology | 1.02690548 |
| 64 | MP0003656_abnormal_erythrocyte_physiolo | 1.02423976 |
| 65 | MP0002254_reproductive_system_inflammat | 1.01688761 |
| 66 | MP0009765_abnormal_xenobiotic_induced | 1.01681423 |
| 67 | MP0006054_spinal_hemorrhage | 1.00839033 |
| 68 | MP0002006_tumorigenesis | 0.99389915 |
| 69 | MP0003183_abnormal_peptide_metabolism | 0.98980430 |
| 70 | MP0003221_abnormal_cardiomyocyte_apopto | 0.98266239 |
| 71 | MP0003195_calcinosis | 0.97668910 |
| 72 | MP0000703_abnormal_thymus_morphology | 0.96130805 |
| 73 | MP0001851_eye_inflammation | 0.94983514 |
| 74 | MP0005390_skeleton_phenotype | 0.94516358 |
| 75 | MP0003045_fibrosis | 0.93220947 |
| 76 | MP0009840_abnormal_foam_cell | 0.88448105 |
| 77 | MP0002166_altered_tumor_susceptibility | 0.88038956 |
| 78 | MP0001663_abnormal_digestive_system | 0.82440485 |
| 79 | MP0000604_amyloidosis | 0.82323898 |
| 80 | MP0002138_abnormal_hepatobiliary_system | 0.81573650 |
| 81 | MP0003690_abnormal_glial_cell | 0.77117084 |
| 82 | MP0001873_stomach_inflammation | 0.71612508 |
| 83 | MP0005058_abnormal_lysosome_morphology | 0.69757338 |
| 84 | MP0010352_gastrointestinal_tract_polyps | 0.69628759 |
| 85 | MP0004381_abnormal_hair_follicle | 0.68055319 |
| 86 | MP0000249_abnormal_blood_vessel | 0.67051830 |
| 87 | MP0002933_joint_inflammation | 0.65612739 |
| 88 | MP0005319_abnormal_enzyme/_coenzyme | 0.63350698 |
| 89 | MP0002396_abnormal_hematopoietic_system | 0.63254351 |
| 90 | MP0004808_abnormal_hematopoietic_stem | 0.62968989 |
| 91 | MP0003795_abnormal_bone_structure | 0.62298788 |
| 92 | MP0008873_increased_physiological_sensi | 0.61473388 |
| 93 | MP0003453_abnormal_keratinocyte_physiol | 0.61466409 |
| 94 | MP0004484_altered_response_of | 0.58337965 |
| 95 | MP0008874_decreased_physiological_sensi | 0.53129087 |
| 96 | MP0002693_abnormal_pancreas_physiology | 0.53100711 |
| 97 | MP0005535_abnormal_body_temperature | 0.52238047 |
| 98 | MP0000609_abnormal_liver_physiology | 0.52080755 |
| 99 | MP0005376_homeostasis/metabolism_phenot | 0.50289075 |
| 100 | MP0000490_abnormal_crypts_of | 0.46917925 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Orchitis (HP:0100796) | 6.86806442 |
| 2 | Retrobulbar optic neuritis (HP:0100654) | 6.77286047 |
| 3 | Optic neuritis (HP:0100653) | 6.77286047 |
| 4 | Myositis (HP:0100614) | 6.53876348 |
| 5 | Stomatitis (HP:0010280) | 6.34111251 |
| 6 | Eczematoid dermatitis (HP:0000976) | 6.00931373 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 5.79191814 |
| 8 | Abnormality of macrophages (HP:0004311) | 5.63959729 |
| 9 | Recurrent abscess formation (HP:0002722) | 5.60516971 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.24200517 |
| 11 | Keratoconjunctivitis sicca (HP:0001097) | 4.84012557 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.71804604 |
| 13 | Keratoconjunctivitis (HP:0001096) | 4.52548844 |
| 14 | Mediastinal lymphadenopathy (HP:0100721) | 4.46687235 |
| 15 | Gastrointestinal infarctions (HP:0005244) | 4.44674410 |
| 16 | Vasculitis (HP:0002633) | 3.93089067 |
| 17 | Recurrent fungal infections (HP:0002841) | 3.92487515 |
| 18 | Recurrent skin infections (HP:0001581) | 3.80382931 |
| 19 | Encephalitis (HP:0002383) | 3.79496106 |
| 20 | Meningitis (HP:0001287) | 3.67089272 |
| 21 | Obstructive lung disease (HP:0006536) | 3.61817245 |
| 22 | Chronic obstructive pulmonary disease (HP:0006510) | 3.61817245 |
| 23 | Pulmonary infiltrates (HP:0002113) | 3.60562956 |
| 24 | Hemoptysis (HP:0002105) | 3.57169659 |
| 25 | Gangrene (HP:0100758) | 3.46343036 |
| 26 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.42606398 |
| 27 | Anorexia (HP:0002039) | 3.42242697 |
| 28 | Urticaria (HP:0001025) | 3.40300441 |
| 29 | T lymphocytopenia (HP:0005403) | 3.38093339 |
| 30 | Episodic fever (HP:0001954) | 3.36441982 |
| 31 | Arterial thrombosis (HP:0004420) | 3.36397260 |
| 32 | Increased IgM level (HP:0003496) | 3.34754872 |
| 33 | Abnormality of T cell number (HP:0011839) | 3.31225187 |
| 34 | Recurrent cutaneous fungal infections (HP:0011370) | 3.28885000 |
| 35 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.28885000 |
| 36 | Amyloidosis (HP:0011034) | 3.13051664 |
| 37 | Gingivitis (HP:0000230) | 3.11314598 |
| 38 | Chest pain (HP:0100749) | 3.11143651 |
| 39 | Leukocytosis (HP:0001974) | 3.01568059 |
| 40 | Peritonitis (HP:0002586) | 2.94889487 |
| 41 | Spontaneous hematomas (HP:0007420) | 2.84427851 |
| 42 | Increased IgE level (HP:0003212) | 2.83569254 |
| 43 | Abnormality of the pleura (HP:0002103) | 2.82202398 |
| 44 | Pulmonary embolism (HP:0002204) | 2.78850422 |
| 45 | Abnormality of T cells (HP:0002843) | 2.71161151 |
| 46 | Recurrent viral infections (HP:0004429) | 2.64752912 |
| 47 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.56794799 |
| 48 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.56794799 |
| 49 | Abnormality of glycolipid metabolism (HP:0010969) | 2.56794799 |
| 50 | Keratitis (HP:0000491) | 2.52776308 |
| 51 | Autoimmune hemolytic anemia (HP:0001890) | 2.46465703 |
| 52 | Glomerulopathy (HP:0100820) | 2.46118718 |
| 53 | Polyneuropathy (HP:0001271) | 2.42927446 |
| 54 | Abnormality of the endocardium (HP:0004306) | 2.41865782 |
| 55 | Gingival bleeding (HP:0000225) | 2.40593738 |
| 56 | Petechiae (HP:0000967) | 2.36195064 |
| 57 | Autoimmune thrombocytopenia (HP:0001973) | 2.34721543 |
| 58 | Cellulitis (HP:0100658) | 2.34586565 |
| 59 | Abnormality of T cell physiology (HP:0011840) | 2.30993923 |
| 60 | Pustule (HP:0200039) | 2.29591972 |
| 61 | Hypergammaglobulinemia (HP:0010702) | 2.29535677 |
| 62 | Premature loss of primary teeth (HP:0006323) | 2.29100839 |
| 63 | Abnormality of the pericardium (HP:0001697) | 2.28430118 |
| 64 | Vertigo (HP:0002321) | 2.27037888 |
| 65 | Loss of speech (HP:0002371) | 2.24920696 |
| 66 | Granulocytopenia (HP:0001913) | 2.22030294 |
| 67 | Abnormality of the peritoneum (HP:0002585) | 2.20603865 |
| 68 | Recurrent bronchitis (HP:0002837) | 2.19873666 |
| 69 | Eosinophilia (HP:0001880) | 2.19253088 |
| 70 | Osteomyelitis (HP:0002754) | 2.18986218 |
| 71 | Prolonged bleeding time (HP:0003010) | 2.17728078 |
| 72 | Acne (HP:0001061) | 2.16470774 |
| 73 | Lymphopenia (HP:0001888) | 2.13031001 |
| 74 | Acute hepatic failure (HP:0006554) | 2.12692123 |
| 75 | Increased serum ferritin (HP:0003281) | 2.11064176 |
| 76 | Sepsis (HP:0100806) | 2.10965998 |
| 77 | Epistaxis (HP:0000421) | 2.09512327 |
| 78 | Disinhibition (HP:0000734) | 2.08152184 |
| 79 | Joint swelling (HP:0001386) | 2.07768755 |
| 80 | Hypochromic microcytic anemia (HP:0004840) | 2.07635158 |
| 81 | Hypochromic anemia (HP:0001931) | 2.05769941 |
| 82 | Amaurosis fugax (HP:0100576) | 2.03938411 |
| 83 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.02865976 |
| 84 | Hepatosplenomegaly (HP:0001433) | 2.01038407 |
| 85 | Chronic otitis media (HP:0000389) | 1.99442357 |
| 86 | Arthralgia (HP:0002829) | 1.92979498 |
| 87 | Thrombophlebitis (HP:0004418) | 1.92842150 |
| 88 | Vacuolated lymphocytes (HP:0001922) | 1.92170732 |
| 89 | Inflammation of the large intestine (HP:0002037) | 1.92128479 |
| 90 | Alveolar cell carcinoma (HP:0006519) | 1.92091404 |
| 91 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.89654895 |
| 92 | IgG deficiency (HP:0004315) | 1.89260877 |
| 93 | Abnormality of eosinophils (HP:0001879) | 1.89184026 |
| 94 | Subacute progressive viral hepatitis (HP:0006572) | 1.88730098 |
| 95 | Increased cerebral lipofuscin (HP:0011813) | 1.88644792 |
| 96 | Abnormality of iron homeostasis (HP:0011031) | 1.88474862 |
| 97 | Hematochezia (HP:0002573) | 1.87754612 |
| 98 | Skin ulcer (HP:0200042) | 1.87250421 |
| 99 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.84947297 |
| 100 | Skin rash (HP:0000988) | 1.83217368 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.25569198 |
| 2 | IRAK4 | 3.97313774 |
| 3 | MAP4K1 | 3.25706557 |
| 4 | BLK | 3.23556167 |
| 5 | IRAK3 | 2.96514835 |
| 6 | TYK2 | 2.96206969 |
| 7 | CSK | 2.93623225 |
| 8 | MAP3K14 | 2.91733710 |
| 9 | TXK | 2.87902942 |
| 10 | MAP2K3 | 2.54022296 |
| 11 | IKBKE | 2.26700483 |
| 12 | SIK3 | 2.23207506 |
| 13 | ZAP70 | 2.08663084 |
| 14 | JAK3 | 2.07267993 |
| 15 | MAP3K3 | 2.06654949 |
| 16 | ERN1 | 2.05066152 |
| 17 | TBK1 | 1.98550134 |
| 18 | FGR | 1.92264418 |
| 19 | BMPR2 | 1.86963010 |
| 20 | IRAK1 | 1.86818430 |
| 21 | MATK | 1.85950304 |
| 22 | EPHB1 | 1.84804100 |
| 23 | FES | 1.77204682 |
| 24 | TAOK3 | 1.76944861 |
| 25 | TAOK1 | 1.68860510 |
| 26 | IKBKB | 1.68290167 |
| 27 | GRK6 | 1.61135055 |
| 28 | JAK2 | 1.59195419 |
| 29 | IRAK2 | 1.56417662 |
| 30 | HCK | 1.54627815 |
| 31 | JAK1 | 1.52328287 |
| 32 | TNK2 | 1.47197122 |
| 33 | MAP3K11 | 1.46598020 |
| 34 | LYN | 1.41637221 |
| 35 | MAP3K13 | 1.39170487 |
| 36 | BTK | 1.36086405 |
| 37 | GRK7 | 1.34184397 |
| 38 | SYK | 1.32071266 |
| 39 | MAP3K1 | 1.31450564 |
| 40 | TAOK2 | 1.27414004 |
| 41 | PRPF4B | 1.23350123 |
| 42 | LCK | 1.07588261 |
| 43 | TGFBR2 | 1.05850907 |
| 44 | STK10 | 1.04365828 |
| 45 | YES1 | 1.01808202 |
| 46 | KSR2 | 1.01502902 |
| 47 | STK24 | 1.01314867 |
| 48 | MARK3 | 0.90734140 |
| 49 | MAP3K5 | 0.85133755 |
| 50 | CSF1R | 0.85115570 |
| 51 | ITK | 0.84923678 |
| 52 | KIT | 0.83003267 |
| 53 | ACVR1B | 0.82762138 |
| 54 | TEC | 0.81360400 |
| 55 | EPHA3 | 0.77378156 |
| 56 | CHUK | 0.76019808 |
| 57 | MAP3K12 | 0.73898610 |
| 58 | MOS | 0.73481016 |
| 59 | MAP3K2 | 0.71514232 |
| 60 | DYRK3 | 0.68760739 |
| 61 | KSR1 | 0.62800193 |
| 62 | MAP2K6 | 0.60818925 |
| 63 | MST4 | 0.57958392 |
| 64 | TESK2 | 0.53551143 |
| 65 | PDK1 | 0.53018169 |
| 66 | PTK6 | 0.47897253 |
| 67 | PIM1 | 0.47653379 |
| 68 | FYN | 0.47154856 |
| 69 | FGFR3 | 0.46179640 |
| 70 | PIK3CG | 0.45944630 |
| 71 | ALK | 0.45716742 |
| 72 | DAPK2 | 0.43703360 |
| 73 | HIPK2 | 0.42158893 |
| 74 | RAF1 | 0.41330316 |
| 75 | PRKCQ | 0.40928041 |
| 76 | CDC42BPA | 0.39397682 |
| 77 | NLK | 0.36695318 |
| 78 | MAP3K6 | 0.36161133 |
| 79 | CDK19 | 0.34812304 |
| 80 | MAP2K4 | 0.34763826 |
| 81 | PTK2B | 0.33987126 |
| 82 | ADRBK2 | 0.33975346 |
| 83 | PDPK1 | 0.33887377 |
| 84 | WNK1 | 0.32070324 |
| 85 | MAPK7 | 0.31896178 |
| 86 | PRKG2 | 0.31629329 |
| 87 | PRKCD | 0.29932271 |
| 88 | MAPKAPK2 | 0.29389680 |
| 89 | ABL1 | 0.27703458 |
| 90 | PAK4 | 0.25625809 |
| 91 | EGFR | 0.24934131 |
| 92 | LRRK2 | 0.23293648 |
| 93 | CLK1 | 0.22878595 |
| 94 | INSR | 0.20286834 |
| 95 | PRKD2 | 0.19257294 |
| 96 | MARK2 | 0.19022516 |
| 97 | STK11 | 0.18616548 |
| 98 | SIK2 | 0.18327342 |
| 99 | FGFR4 | 0.16947656 |
| 100 | MAP3K8 | 0.16222927 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.21673262 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 3.01021318 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.84852617 |
| 4 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.81768854 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.78203962 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.76379786 |
| 7 | Legionellosis_Homo sapiens_hsa05134 | 2.65767438 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.62432435 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.52806342 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.46736290 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.42289009 |
| 12 | Malaria_Homo sapiens_hsa05144 | 2.32388985 |
| 13 | Tuberculosis_Homo sapiens_hsa05152 | 2.26889558 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.20021099 |
| 15 | Measles_Homo sapiens_hsa05162 | 2.02612095 |
| 16 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.01916499 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.00330481 |
| 18 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.96881289 |
| 19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.88985196 |
| 20 | Influenza A_Homo sapiens_hsa05164 | 1.82849285 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.80247773 |
| 22 | Asthma_Homo sapiens_hsa05310 | 1.77012752 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.70601706 |
| 24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.69228928 |
| 25 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.68368199 |
| 26 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.66870814 |
| 27 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.65192022 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.62495985 |
| 29 | Pertussis_Homo sapiens_hsa05133 | 1.61510004 |
| 30 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.61258132 |
| 31 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.58774227 |
| 32 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.58709393 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.58270475 |
| 34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.54344851 |
| 35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.54091366 |
| 36 | Salmonella infection_Homo sapiens_hsa05132 | 1.52801949 |
| 37 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.49314334 |
| 38 | Viral myocarditis_Homo sapiens_hsa05416 | 1.46080359 |
| 39 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.40897517 |
| 40 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.38031182 |
| 41 | Phagosome_Homo sapiens_hsa04145 | 1.36901383 |
| 42 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.31846486 |
| 43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.25073899 |
| 44 | Shigellosis_Homo sapiens_hsa05131 | 1.24571659 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 1.19487303 |
| 46 | Hepatitis C_Homo sapiens_hsa05160 | 1.17289344 |
| 47 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.05693118 |
| 48 | Apoptosis_Homo sapiens_hsa04210 | 0.92513335 |
| 49 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.80835653 |
| 50 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.79516687 |
| 51 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.78479549 |
| 52 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.77152251 |
| 53 | Lysosome_Homo sapiens_hsa04142 | 0.74193332 |
| 54 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.73703094 |
| 55 | Amoebiasis_Homo sapiens_hsa05146 | 0.73049478 |
| 56 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.69134500 |
| 57 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.68670217 |
| 58 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.68608851 |
| 59 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64230953 |
| 60 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61721120 |
| 61 | Other glycan degradation_Homo sapiens_hsa00511 | 0.61121828 |
| 62 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.60720524 |
| 63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.59829210 |
| 64 | Platelet activation_Homo sapiens_hsa04611 | 0.59718334 |
| 65 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58146770 |
| 66 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56985896 |
| 67 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.54322756 |
| 68 | Bladder cancer_Homo sapiens_hsa05219 | 0.53763691 |
| 69 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.52840673 |
| 70 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.52774721 |
| 71 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.49673581 |
| 72 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47505012 |
| 73 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.47208891 |
| 74 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44857988 |
| 75 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.44608717 |
| 76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44243755 |
| 77 | HTLV-I infection_Homo sapiens_hsa05166 | 0.43080283 |
| 78 | Endocytosis_Homo sapiens_hsa04144 | 0.43047969 |
| 79 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.42023881 |
| 80 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41033752 |
| 81 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.40501600 |
| 82 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.37899140 |
| 83 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.37378010 |
| 84 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.33015988 |
| 85 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.30691518 |
| 86 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.29521503 |
| 87 | Prion diseases_Homo sapiens_hsa05020 | 0.24793994 |
| 88 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.24586416 |
| 89 | Insulin resistance_Homo sapiens_hsa04931 | 0.24109844 |
| 90 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.22722640 |
| 91 | Mineral absorption_Homo sapiens_hsa04978 | 0.19578173 |
| 92 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.18850160 |
| 93 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.18090930 |
| 94 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.14792026 |
| 95 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.14572283 |
| 96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.13829685 |
| 97 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.11014620 |
| 98 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.10216282 |
| 99 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.09935034 |
| 100 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.08535771 |

